Publications

5802 Results

Quality of life end points in cancer clinical trials: Review and Recommendations

Authors
CM Moinpour;P Feigl;B Metch;KA Hayden;FL Meyskens;J Crowley
Journal / Conference
JCO 8(7):485-495
Year
1989

Localized (stage I & II, A & B), hodgkin's disease treated with extended field radiotherapy vs. involved field radiotherapy plus MOPP with 16 year followup: A Southwest Oncology Group study.

Authors
C Coltman, Jr;S Dahlberg;L Fuller;E Frei
Journal / Conference
ASCO 8:252(#981)
Year
1989
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-781

Long-term followup of patients with low grade lymphoma treated with CHOP ( cyclophosphamide, doxorubicin, vincristine, prednisone)-based chemotherapy or chemoimmunotherapy on Southwest Oncology Group studies

Authors
B Dana;S Dahlberg;T Miller;S Jones;E Chase;C Coltman, Jr;R Fisher
Journal / Conference
ASCO 8:257(#1001)
Year
1989
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14

Long-term survival of patients with nodular histiocytic (NH),diffuse poorly differentiated lymphocytic (DPDL), diffuse mixed (DM),and diffuse undifferentiated (DU) lymphoma treated with CHOP chemotherapy.

Authors
RI Fisher;S Dahlberg;TP Miller;SE Jones;C Coltman, Jr
Journal / Conference
ASCO 8:257(#1003)
Year
1989
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14

Adjuvant combination chemotherapy (CMFVP) vs L-phenylalanine mustard (LPAM) for operable breast cancer with positive axillary lymph nodes: 10 year results.

Authors
S Rivkin;S Green;CK Osborne;B Metch;H Glucksberg;R McDivitt;N Gad-el-Mawla;R Stephens;J Costanzi
Journal / Conference
ASCO 8:24(#89)
Year
1989
Research Committee(s)
Breast
Study Number(s)
SWOG-7436

Long term followup in the cure of osteogenic sarcoma.

Authors
L Baker;J Crowley;J Ryan;R Benjamin;W Murphy;S Balcerzak;J Gottlieb
Journal / Conference
ASCO 8:320(#1244)
Year
1989
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-7440

After resection of large bowel carcinoma, immune status is often depressed. Data from a SWOG study.

Authors
FJ Panettiere
Journal / Conference
ASCO 8:107(#415)
Year
1989
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7510

A retrospective comparison of high dose BCNU with autologous marrow rescue plus radiotherapy vs. IV BCNU plus radiation therapy in high grade gliomas: A Southwest Oncology Group review.

Authors
W Goodwin;J Crowley
Journal / Conference
ASCO 8:90(#352)
Year
1989
Research Committee(s)
Brain
Study Number(s)
SWOG-7703

Efficacy of low dose involved field (LDIF) XRT in producing and maintaining CR following PR induction with MOP-BAP chemotherapy in hodgkin's disease, results of Southwest Oncology Group study 7808

Authors
C Fabian;S Dahlberg;T Miller;S Jones;P Grozea;F Morrison;C Mansfield
Journal / Conference
ASCO 8:253(#987)
Year
1989
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7808

Adjuvant chemotherapy for poor prognosis estrogen receptor negative stage II-III breast cancer; a comparison of one year vs two years CMFVP.

Authors
S Green;S Rivkin;B Metch;CK Osborne;A Cruz;S Balcerzak;R Stevens;J Costanzi
Journal / Conference
ASCO 8:24(#88)
Year
1989
Research Committee(s)
Breast
Study Number(s)
SWOG-7827